Skip to main content
Top

Current Oncology Reports

Issue 5/2017

Content (6 Articles)

Leukemia (A Aguayo, Section Editor)

Philadelphia-Like Acute Lymphoblastic Leukemia in Adults

Tobias Herold, Nicola Gökbuget

Open Access Gastrointestinal Cancers (J Meyer, Section Editor)

Immunotherapy for Esophageal Squamous Cell Carcinoma

Takashi Kojima, Toshihiko Doi

Lymphomas (MR Smith, Section Editor)

Optimal Therapy for Early-Stage Hodgkin’s Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy

Andrea Riccardo Filippi, Mario Levis, Rahul Parikh, Bradford Hoppe

Genitourinary Cancers (DP Petrylak and JW Kim, Section Editors)

Emerging Variants of Castration-Resistant Prostate Cancer

Panagiotis J. Vlachostergios, Loredana Puca, Himisha Beltran

Melanoma (RJ Sullivan, Section Editor)

Adjuvant Therapy for Melanoma

Aya Agha, Ahmad A. Tarhini

Breast Cancer (B Overmoyer, Section Editor)

The Evolving Role of the Estrogen Receptor Mutations in Endocrine Therapy-Resistant Breast Cancer

Rinath Jeselsohn, Carmine De Angelis, Myles Brown, Rachel Schiff

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine